Aptus Pharma Ltd

BSE: 544529 · Pharmaceuticals & Biotechnology · 30 announcements

Share price: ₹480.00
Market cap: ₹823.2 Cr
Revenue (annual): ₹46.57 Cr
Net profit (annual): ₹4.62 Cr
P/E (TTM): 178.2×Sector 43.8×
Promoter holding: 72.89%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Annual General Meeting 2 Preferential Issue 1 Other Announcement 1 Fund Raise 1 Financial Results 1 Earnings Call 1 Capital Structure Change 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

24 Aug 2026 13:34 IST BSE

Fund RaiseAlfa Alert

Aptus Pharma Fund Raise of ₹44.88 Cr

Aptus Pharma Limited's Board has approved raising ₹44.88 Crore through a preferential equity issue. Funds will support manufacturing capacity expansion, working capital, and Pan-India growth initiatives.

Value: ₹44.88 Cr
Execution: 36 months

Open announcement → Read the filing ↗